it’s an acceptance of the phase 1 and be an IND can be submitted at any stage of the drug development but needs to be recognised by the FDA
Australia is gold standards when it comes to biotech research. GLP coming up de risk the drug and the phase 1 de risks the drug further. Walter Reed de risks it even more and we get a 5-10 million dollar grant. We paid 150k to receive a 5-10 million dollar non dilutive grant are you upset Hawk70?
it’s an acceptance of the phase 1 and be an IND can be submitted...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.3¢ |
Change
0.016(28.1%) |
Mkt cap ! $13.09M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 7.7¢ | 6.0¢ | $61.01K | 881.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.8¢ | 35100 | 1 |
View Market Depth
| Last trade - 15.57pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.3¢ |
Change
0.016 ( 28.1 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 7.6¢ | 6.3¢ | 455079 | ||
| Last updated 15.37pm 03/06/2024 ? | |||||
| NYR (ASX) Chart |